Highlights of the important and interesting in the world of healthcare:
Journey of a whistleblower. In 2002, drug maker GlaxoSmithKline sent one of its quality-assurance managers to Puerto Rico to help clean up a mess at one of its biggest manufacturing plants. Cheryl Eckard’s journey ended this week with the largest ever U.S. whistleblower award — at least $96 million, the Wall Street Journal reports.
VC sentiment rebounds… a little. VCs are feeling slightly more confident about their industry than they did in the second quarter, according to the latest Silicon Valley Venture Capitalist Confidence Index, PEHub reports.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Chicago doctors goo-goo for iPads. Beyond using iPads to research clinical information or access electronic medical records, Chicago doctors increasingly are using the device to interact with patients, according to the medGadget blog.
Doorway to collaborative medicine. The alchemy of adding online social networking to medicine — for both patients and clinicians — disrupts traditional relationships that repeat the same-old care patterns and flat outcomes, opens up data silos and enables collaborative healthcare that improves outcomes and reduces costs, according to the HEALTHPopuli blog.
You say potato, I say… Two companies seeing the same news on Medicare differently killed the merger of ExonHit Therapeutics SA and venture-backed RedPath Integrated Pathology Inc., according to Dow Jones VentureWire Lifescience (paid subscription required).
Reform boosts M&A? Healthcare reform is likely to spur mergers and acquisitions, particularly among medical groups, according to a new report by Deloitte Development LLC, FierceHealthFinance reports.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Buy health insurance, or else. The individual mandate that’s part of healthcare reform law should hold up in court as constitutional, attorney Sara Rosenbaum of the department of health policy at George Washington University in Washington, wrote online in the New England Journal of Medicine.
